SCHEMBL4850139

SCHEMBL4850139

CC(=O)Nc1ccc(F)cc1OCC(O)CN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 13/20 0.59
PLD2 O14939 12/20 0.59
CCR1 P32246 3/20 0.56
OPRL1 P41146 2/20 0.54
DRD2 P14416 2/20 0.53
HTR1A P08908 1/20 0.49
ADRA2A P08913 1/20 0.49
HTR2A P28223 1/20 0.49
SLC6A4 P31645 1/20 0.49
DRD3 P35462 1/20 0.49
KCNH2 Q12809 2/20 0.48
YEATS4 O95619 1/20 0.48
MLLT3 P42568 1/20 0.48
MLLT1 Q03111 1/20 0.48
YEATS2 Q9ULM3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4807137 0.93 PLD1 (0.59) PLD1PLD2CCR1OPRL1DRD2
SCHEMBL6628489 0.92 OPRL1 (0.60) PLD1PLD2CCR1OPRL1DRD2
SCHEMBL6628494 0.92 OPRL1 (0.60) PLD1PLD2CCR1OPRL1DRD2
Trifluoroacetic Acid SCHEMBL4804354 0.90 PLD2 (0.53) PLD1PLD2CCR1OPRL1DRD2
SCHEMBL4809028 0.90 CCR1 (0.55) PLD1PLD2CCR1OPRL1KCNH2
SCHEMBL4809038 0.90 CCR1 (0.55) PLD1PLD2CCR1OPRL1KCNH2
SCHEMBL4808944 0.89 OPRL1 (0.57) PLD1PLD2CCR1OPRL1DRD2
SCHEMBL4807964 0.89 PLD2 (0.53) PLD1PLD2CCR1OPRL1
SCHEMBL4807955 0.89 PLD2 (0.53) PLD1PLD2CCR1OPRL1
Hydrochloric Acid SCHEMBL4805706 0.89 OPRL1 (0.56) PLD1PLD2CCR1OPRL1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388020-B2 Benzimidazol derivatives modulate chemokine receptors ASTRAZENECA AB (SE) 2008-06-17 US claimed
US-7388020-B2 Benzimidazol derivatives modulate chemokine receptors ASTRAZENECA AB (SE) 2008-06-17 US disclosed
US-20040116435-A1 Benzimidazol derivatives modulate chemokine receptors ASTRAZENECA AB (SE) 2004-06-17 US disclosed
EP-1373248-A1 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS AstraZeneca AB (SE) 2004-01-02 EP disclosed
WO-2002074763-A9 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS ASTRAZENECA AB (SE) 2002-10-24 WO disclosed
WO-2002074763-A1 BENZIMIDAZOL DERIVATIVES MODULATE CHEMOKINE RECEPTORS ASTRAZENECA AB (SE) 2002-09-26 WO disclosed